https://drugnews.com.tw/articles/2026-08-23-big-pharma-biotech-ma-next-targets-2026-en.html Drugnews｜藥時事 en 2026-08-23T00:00:00.000Z Who Could Be Big Pharma's Next Major Biotech Acquisition? https://drugnews.com.tw/articles/2026-08-23-big-pharma-biotech-ma-next-targets-2026.html Drugnews｜藥時事 zh-tw 2026-08-23T00:00:00.000Z Biotech 下一筆重磅併購，會落在誰身上？ https://drugnews.com.tw/articles/2026-08-22-revolution-medicines-beone-four-ras-programs-en.html Drugnews｜藥時事 en 2026-08-22T00:00:00.000Z BeOne Bets on Four RAS Drugs: The Real Asset Is Development Optionality https://drugnews.com.tw/articles/2026-08-22-revolution-medicines-beone-four-ras-programs.html Drugnews｜藥時事 zh-tw 2026-08-22T00:00:00.000Z 百濟神州一口氣押上 4 款 RAS 新藥